The discovery has shed light on a complex blood interaction that has likely always been present in humans but was unnoticed ...
AstraZeneca is expecting Phase III trial data for seven new medicines in 2025, its CEO said as he confirmed the company’s ...
AstraZeneca's Imfinzi perioperative regimen improved survival outcomes in muscle-invasive bladder cancer, with FDA Priority ...
Havant MP Alan Mak has demanded to know why the Labour Government chose to walk away from a £450m investment deal with ...
Indicates growing incidence of cancer among Indian population; five out of top 20 new brand launches are cancer drugs ...
Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.
A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and ...
A coroner overseeing the inquest of a woman who died following a Covid vaccine has stood down amid claims of bias and ...
1d
News Medical on MSNResearchers uncover cause of persistent blood clots despite treatmentA team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with full-dose ...
In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2 billion. However many analysts felt the company had paid far too much ...
Hosted on MSN5d
Peer demands answers on AstraZeneca deal collapseIt previously defended its negotiations with AstraZeneca, blaming a shortfall in government ... The plan to expand the site, ...
5d
IFLScience on MSNMontana Considers Becoming First US State To Ban mRNA Vaccine UseOn Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA vaccines in humans. The bill was sponsored by State Representative Greg Kmetz with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results